Related Experiment Video

Updated: Jun 15, 2026

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
10:35

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo

Published on: April 6, 2022

Novel inhibitors of basal glucose transport as potential anticancer agents

Weihe Zhang1, Yi Liu, Xiaozhuo Chen

  • 1Department of Chemistry & Biochemistry, Ohio University, Athens, OH 45701, USA.

Bioorganic & Medicinal Chemistry Letters
|March 3, 2010
PubMed

Insights

Researchers developed new polyphenolic esters to block glucose transport in cancer cells. These compounds effectively inhibit cancer cell growth, suggesting a new therapeutic strategy for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer cells exhibit elevated glucose uptake and rely heavily on it for survival and proliferation.
  • Targeting basal glucose transport presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To synthesize and evaluate a library of polyphenolic esters as inhibitors of basal glucose transport.
  • To assess the impact of these inhibitors on cancer cell growth, specifically in H1299 lung cancer cells.

Main Methods:

  • Synthesis of a small library of novel polyphenolic esters.
  • Assay of basal glucose transport inhibition in H1299 lung cancer cells and other cancer cell lines.
  • Evaluation of the antiproliferative effects of the synthesized compounds on cancer cells.

Main Results:

  • The synthesized polyphenolic esters effectively inhibited basal glucose transport in H1299 lung cancer cells.
  • These compounds also demonstrated significant inhibition of cancer cell growth in H1299 cells.
  • A strong correlation was observed between the inhibition of basal glucose transport and the inhibition of cancer cell growth.

Conclusions:

  • Polyphenolic esters are effective inhibitors of basal glucose transport in cancer cells.
  • Inhibition of basal glucose transport by these compounds correlates with their anti-cancer growth activity.
  • This study highlights a promising avenue for developing novel cancer therapeutics targeting glucose metabolism.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...